The clinical trials below are available in the specialty you selected. Choose a different specialty.
A Prospective Randomized Phase III Translational NIH Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
This study seeks adult cancer patients to determine if a daily injection of a blood-thinner, dalteparin, for three months can safely and effectively reduce the frequency of blood clots in patients at increased risk. (REF# 11739)
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Resectable MAGE-A3 Positive Non-Small Cell Lung Cancer
This study seeks lung cancer patients to test the benefit of an immunotherapeutic treatment. (REF# 22918)